Literature DB >> 11197533

VEGF enhances intraneural angiogenesis and improves nerve regeneration after axotomy.

M I Hobson1, C J Green, G Terenghi.   

Abstract

Whilst there is an increased understanding of the cell biology of nerve regeneration, it remains unclear whether there is a direct interrelationship between vascularisation and efficacy of nerve regeneration within a nerve conduit. To establish this is important as in clinical surgery peripheral nerve conduit grafting has been widely investigated as a possible alternative to the use of nerve autografts. The aim of this study was to assess whether vascular endothelial growth factor (VEGF), a highly specific endothelial cell mitogen, can enhance vascularisation and, indirectly, axonal regeneration within a silicone nerve regeneration chamber. Chambers containing VEGF (500-700 ng/ml) in a laminin-based gel (Matrigel) were inserted into 1 cm rat sciatic nerve defects and nerve regeneration examined in relation to angiogenesis between 5 and 180 d. Longitudinal sections were stained with antibodies against endothelial cells (RECA-1), axons (neurofilament) and Schwann cells (S-100) to follow the progression of vascular and neural elements. Computerised image analysis demonstrated that the addition of VEGF significantly increased blood vessel penetration within the chamber from d 5, and by d 10 this correlated with an increase of axonal regeneration and Schwann cell migration. The pattern of increased nerve regeneration due to VEGF administration was maintained up to 180 d, when myelinated axon counts were increased by 78 % compared with plain Matrigel control. Furthermore the dose-response of blood vessel regeneration to VEGF was clearly reflected in the increase of axonal regrowth and Schwann cell proliferation, indicating the close relationship between regenerating nerves and blood vessels within the chamber. Target organ reinnervation was enhanced by VEGF at 180 d as measured through the recovery of gastrocnemius muscle weights and footpad axonal terminal density, the latter showing a significant increase over controls (P < 0.05). The results demonstrate an overall relationship between increased vascularisation and enhanced nerve regeneration within an acellular conduit, and highlight the interdependence of the 2 processes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11197533      PMCID: PMC1468175          DOI: 10.1046/j.1469-7580.2000.19740591.x

Source DB:  PubMed          Journal:  J Anat        ISSN: 0021-8782            Impact factor:   2.610


  48 in total

1.  Inter-relationships between angiogenesis and nerve regeneration: a histochemical study.

Authors:  M I Hobson; R Brown; C J Green; G Terenghi
Journal:  Br J Plast Surg       Date:  1997-02

2.  A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor.

Authors:  A Passaniti; R M Taylor; R Pili; Y Guo; P V Long; J A Haney; R R Pauly; D S Grant; G R Martin
Journal:  Lab Invest       Date:  1992-10       Impact factor: 5.662

3.  Sciatic function index, nerve conduction tests, muscle contraction, and axon morphometry as indicators of regeneration.

Authors:  F Kanaya; J C Firrell; W C Breidenbach
Journal:  Plast Reconstr Surg       Date:  1996-12       Impact factor: 4.730

4.  Increased rate of peripheral nerve regeneration using bioresorbable nerve guides and a laminin-containing gel.

Authors:  R Madison; C F da Silva; P Dikkes; T H Chiu; R L Sidman
Journal:  Exp Neurol       Date:  1985-06       Impact factor: 5.330

5.  The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules.

Authors:  H Gitay-Goren; S Soker; I Vlodavsky; G Neufeld
Journal:  J Biol Chem       Date:  1992-03-25       Impact factor: 5.157

6.  High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis.

Authors:  B Millauer; S Wizigmann-Voos; H Schnürch; R Martinez; N P Møller; W Risau; A Ullrich
Journal:  Cell       Date:  1993-03-26       Impact factor: 41.582

7.  A diffusion-reaction model of nerve regeneration.

Authors:  R J Podhajsky; R R Myers
Journal:  J Neurosci Methods       Date:  1995-08       Impact factor: 2.390

Review 8.  Scatter factor and angiogenesis.

Authors:  E M Rosen; I D Goldberg
Journal:  Adv Cancer Res       Date:  1995       Impact factor: 6.242

9.  Spontaneous discharge of afferents in a neuroma reflects original receptor tuning.

Authors:  M Devor; C H Keller; M H Ellisman
Journal:  Brain Res       Date:  1990-05-28       Impact factor: 3.252

10.  Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration.

Authors:  M Clauss; M Gerlach; H Gerlach; J Brett; F Wang; P C Familletti; Y C Pan; J V Olander; D T Connolly; D Stern
Journal:  J Exp Med       Date:  1990-12-01       Impact factor: 14.307

View more
  67 in total

1.  Vascular endothelial growth factor and fibroblast growth factor 2 delivery from spinal cord bridges to enhance angiogenesis following injury.

Authors:  Laura De Laporte; Anne des Rieux; Hannah M Tuinstra; Marina L Zelivyanskaya; Nora M De Clerck; Andrei A Postnov; Véronique Préat; Lonnie D Shea
Journal:  J Biomed Mater Res A       Date:  2011-05-31       Impact factor: 4.396

2.  Overcoming endogenous constraints on neuronal regeneration.

Authors:  Nassir Mokarram; Ravi V Bellamkonda
Journal:  IEEE Trans Biomed Eng       Date:  2010-12-30       Impact factor: 4.538

Review 3.  Motor neuron trophic factors: therapeutic use in ALS?

Authors:  Thomas W Gould; Ronald W Oppenheim
Journal:  Brain Res Rev       Date:  2010-10-21

4.  In vitro analysis of PNIPAAm-PEG, a novel, injectable scaffold for spinal cord repair.

Authors:  Noelle Comolli; Birgit Neuhuber; Itzhak Fischer; Anthony Lowman
Journal:  Acta Biomater       Date:  2008-10-26       Impact factor: 8.947

Review 5.  Platelet-Rich Plasma Promotes Axon Regeneration, Wound Healing, and Pain Reduction: Fact or Fiction.

Authors:  Damien P Kuffler
Journal:  Mol Neurobiol       Date:  2015-06-06       Impact factor: 5.590

6.  Exogenous pleiotrophin applied to lesioned nerve impairs muscle reinnervation.

Authors:  Brigitte Blondet; Gilles Carpentier; Arnaud Ferry; José Courty
Journal:  Neurochem Res       Date:  2006-06-29       Impact factor: 3.996

7.  VEGF-A promotes both pro-angiogenic and neurotrophic capacities for nerve recovery after compressive neuropathy in rats.

Authors:  Julien Pelletier; Emilie Roudier; Pierre Abraham; Bérengère Fromy; Jean Louis Saumet; Olivier Birot; Dominique Sigaudo-Roussel
Journal:  Mol Neurobiol       Date:  2014-05-28       Impact factor: 5.590

Review 8.  Vascular endothelial growth factor (VEGF) in seizures: a double-edged sword.

Authors:  Susan D Croll; Jeffrey H Goodman; Helen E Scharfman
Journal:  Adv Exp Med Biol       Date:  2004       Impact factor: 2.622

9.  Neurotrophic growth factors for the treatment of amyotrophic lateral sclerosis: where do we stand?

Authors:  Alexandre Henriques; Claudia Pitzer; Armin Schneider
Journal:  Front Neurosci       Date:  2010-06-11       Impact factor: 4.677

10.  Effects of vascular endothelial cell growth factor on fibrovascular ingrowth into rabbits hydroxyapatite orbital implant.

Authors:  Hong Zhang; Guigang Li; Caini Ji; Hua He; Junming Wang; Weikun Hu; Hua Wu; Jing Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2004
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.